ThoroughCare | $5,000,000 | (Nov 20, 2024)
OneChronos | $32,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
The Wound Company
United States
- Minneapolis, MN
- 19/07/2023
- Seed
- $4,250,000
The Wound Company is fixing the broken space of wound and ostomy care by using predictive analytics and multi-channel communications to deliver the right wound and ostomy care to the right patient in the right channel at the right time. The tech connects patients and providers to on-demand wound and ostomy experts virtually or via in-person visits to ensure they have top-tier care.
The Wound company partners with health plans, at-risk providers, home health providers, and hospice care providers, to help reduce cost of care and increase patient outcomes.
- Industry Hospital & Health Care
- Website https://www.thewound.co/
- LinkedIn https://www.linkedin.com/company/wound-co/
Related People
Nima AhmadiCo Founder
United States -
Minneapolis, Minnesota
“Of all the forms of inequality, injustice in healthcare is the most shocking and inhumane" - MLK.
Nima Ahmadi is an accomplished healthcare entrepreneur and executive dedicated to revolutionizing care for wound and ostomy patients to eliminate a small part of the injustices in the industry. With an unwavering commitment to effective and holistic treatment, he has a lifelong passion for developing and commercializing solutions to transform the lives of patients worldwide.
Nima has worked on both the payer and patient engagement side as the VP of Product at Icario, where he grew the platform from 0 to 15 million Medicare Advantage and Medicaid patients for top-tier health plans, and on the medical device side of the wound care industry as the Head of Strategic Ventures and Digital Products at Cardiovascular System Inc.
His unique career experiences make him well-positioned as the CEO of The Wound Company, where he is connecting patients and providers to wound care experts to help people heal, save limbs and save lives.
Jimini Health | $8,000,000 | (Nov 20, 2024)
Theranautilus | $1,200,000 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
Seen Health | $22,000,000 | (Nov 19, 2024)
GEMESYS | $9,058,380 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)